Aggressive Subtypes of Papillary Thyroid Cancer Deserve Increased Attention
Although papillary thyroid carcinoma subtypes are often lumped together, mortality risk varied greatly across subtypes.
Head and Neck Cancer
Promising Clinical Activity for RT Plus ICIs in Locally Advanced Head and Neck Cancers
The majority of patients enrolled in this study were unable to receive cisplatin due to an ear-related comorbidity.
Head and Neck Cancers Treatment Regimens
View detailed treatment regimens for head and neck cancers, with options such as cisplatin, cisplatin + radiotherapy, and more.
Assessment for Vulnerability Improves Outcomes for Patients With HNC Undergoing Concurrent Chemoradiotherapy
Comprehensive geriatric assessment was shown to effectively identify vulnerability to AEs in patients with HNC across all ages.
No Local Control or OS Benefit Seen With RT Dose Escalation in Inoperable Esophageal Cancer
In this study, patients were randomly assigned to receive standard-dose RT or standard-dose RT plus an integrated RT boost to the primary tumor.
Mortality Risk in Oropharynx Cancer Varies Based on HPV Status
Patients with OPC with HPV-negative tumors have increased risk for head and neck cancer mortality.
Routine HPV Testing May Be Warranted for Sinonasal Cancers
HPV-positive sinonasal squamous cell carcinoma associated with improved overall survival.
Endoscopic Approaches Feasible in Surgery for Sinonasal Cancer
Overall, 87.4 percent of 239 patients achieved negative margins with endoscopic resection.
U.S. Incidence of Thyroid Cancer Plateaued in 2009
Significant slowing found in rate of increase from 2009 to 2014, followed by stable rate since 2014.
Initial Therapy of Advanced Anaplastic Thyroid Cancer via Targeting VEGFR-2: A Case Report
[OncoTargets and Therapy] Researchers outline the case of a 93-year-old female with advanced ATC who received initial treatment with apatinib.
